IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v563y2018i7732d10.1038_s41586-018-0580-6.html
   My bibliography  Save this article

Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

Author

Listed:
  • Christine M. Fillmore

    (Stem Cell Program, Boston Children’s Hospital
    Department of Genetics, Harvard Medical School
    Harvard Stem Cell Institute)

  • Chunxiao Xu

    (Department of Medical Oncology, Dana-Farber Cancer Institute
    Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute)

  • Pooja T. Desai

    (Stem Cell Program, Boston Children’s Hospital)

  • Joanne M. Berry

    (Stem Cell Program, Boston Children’s Hospital)

  • Samuel P. Rowbotham

    (Stem Cell Program, Boston Children’s Hospital
    Department of Genetics, Harvard Medical School
    Harvard Stem Cell Institute)

  • Yi-Jang Lin

    (Department of Genetics, Harvard Medical School)

  • Haikuo Zhang

    (Department of Medical Oncology, Dana-Farber Cancer Institute
    Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute)

  • Victor E. Marquez

    (Chemical Biology Laboratory, National Cancer Institute, National Institutes of Health)

  • Peter S. Hammerman

    (Department of Medical Oncology, Dana-Farber Cancer Institute)

  • Kwok-Kin Wong

    (Department of Medical Oncology, Dana-Farber Cancer Institute
    Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute)

  • Carla F. Kim

    (Stem Cell Program, Boston Children’s Hospital
    Department of Genetics, Harvard Medical School
    Harvard Stem Cell Institute)

Abstract

We wish to correct two mutations in Supplementary Table 4 of this Letter. The NCI-H460 cell line was annotated as being mutant for TP53. NCI-H460 has been verified to be TP53 wild type by several sources1. The NCI-H2009 cell line was annotated as being mutant for PIK3CA. As annotated by COSMIC (ref. 24 of the original Letter) and CCLE (ref. 25 of the original Letter), the NCI-H2009 cell line has a mutation in PIK3C3, rather than PIK3CA. The cell line is wild type for PIK3CA. The Supplementary Information of this Amendment contains the corrected Supplementary Table 4. These errors do not affect our conclusions. The original Letter has not been corrected.

Suggested Citation

  • Christine M. Fillmore & Chunxiao Xu & Pooja T. Desai & Joanne M. Berry & Samuel P. Rowbotham & Yi-Jang Lin & Haikuo Zhang & Victor E. Marquez & Peter S. Hammerman & Kwok-Kin Wong & Carla F. Kim, 2018. "Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors," Nature, Nature, vol. 563(7732), pages 27-27, November.
    • Handle: RePEc:nat:nature:v:563:y:2018:i:7732:d:10.1038_s41586-018-0580-6
    DOI: 10.1038/s41586-018-0580-6
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41586-018-0580-6
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41586-018-0580-6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:563:y:2018:i:7732:d:10.1038_s41586-018-0580-6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.